Erica S Tsang

10PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 29, 2026
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial.

|Sep 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Jennifer J Knox, Grainne O'Kane, Daniel King

|Nov 07, 2024
Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies.

Erica S Tsang, Rahul R Aggarwal, Emily K Bergsland

|Jun 12, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.

Erica S Tsang, Mallika S Dhawan, Romain Pacaud

|Oct 03, 2023
Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer.

Erica S Tsang, Steven Gallinger

|Mar 25, 2023
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration.

Erica S Tsang, Veronika Csizmok, Laura M Williamson

Pageof 2

Frequent Collaborators

2 joint publications

Jonathan M Loree

2 joint publications

Eileen M O'Reilly

2 joint publications

Daniel J Renouf

2 joint publications

Jennifer J Knox